Preparation of dendritic cells for cancer immunotherapy

Biomedit︠s︡inskai︠a︡ khimii︠a︡
Zh K Nazarkina, P P Laktionov

Abstract

Development of new effective method for cancer therapy is one of the most important trends in the modern medicine. Along with surgery, chemotherapy and radiotherapy, induction of an immune response against the tumor cells is a promising approach for therapy of cancer, particularly metastatic, slowly dividing tumors and cancer stem cells. Induction of the antitumor T-cell immune response involves activation of antigen-presenting cells, which can efficiently present the cancer antigens and activate T-lymphocytes. The immune response may be activated by dendritic cells (DC) loaded with tumor antigens, such as tumor-specific proteins, tumor cell lysates, apoptotic or necrotic tumor cells, as well as nucleic acids encoding tumor antigens. Regardless of the selected source of the tumor antigen, preparation of mature DC is a principal step in the development of anticancer vaccines aimed at the induction of the cytotoxic T-cell immune response. Recently, various research groups have proposed several strategies for producing mature DC, differed by the set of agents used. It has been shown that the maturation strategy influences both their phenotype and the ability to induce the immune response. In this review we have analyzed the result...Continue Reading

References

Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Feb 28, 2002·Annual Review of Immunology·Pierre GuermonprezSebastian Amigorena
Sep 7, 2002·Journal of Immunological Methods·Thomas G BergerBeatrice Schuler-Thurner
Nov 13, 2003·Experimental and Molecular Pathology·Smaroula DilioglouRobert E Lewis
Nov 15, 2003·Biological Procedures Online·Bianca ObermaierAndreas Eigler
Nov 18, 2003·Immunological Reviews·Adrian E Morelli, Angus W Thomson
May 4, 2004·Nature Medicine·Carl G FigdorCornelis J M Melief
Aug 3, 2004·Nature Reviews. Immunology·Michael J Bevan
Apr 26, 2005·Journal of Immunological Methods·Thomas G BergerGerold Schuler
Jan 31, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·William K DeckerElizabeth J Shpall
Apr 10, 2007·Cell·Steven L Reiner
Apr 14, 2007·Journal of Translational Medicine·Anke ZobywalskiDolores J Schendel
May 12, 2007·European Journal of Immunology·Peter DubskyA Karolina Palucka
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sanju IwamotoAkira Miyazaki
Sep 14, 2007·Immunological Reviews·Hideki UenoJacques Banchereau
Dec 28, 2007·Experimental & Molecular Medicine·Chien-Fu HungT-C Wu
Jan 10, 2008·Journal of Leukocyte Biology·Manfred LehnerWolfgang Holter
Mar 28, 2008·Journal of Cellular and Molecular Medicine·Alexander Michael DohnalThomas Felzmann
Nov 26, 2008·Handbook of Experimental Pharmacology·Stefano Maria SantiniMaria Ferrantini
Dec 22, 2009·Journal of Translational Medicine·Sébastien AnguilleVigor F I Van Tendeloo
Jul 29, 2010·Vaccine·Katerina SkalovaJaroslav Michalek
Sep 21, 2010·European Journal of Immunology·Gerold Schuler
Nov 26, 2010·Journal of Immunological Methods·Amanda CobbJacques Banchereau
Jan 25, 2011·Cancer Immunology, Immunotherapy : CII·Luciano CastielloDavid F Stroncek
Nov 23, 2011·Immunologic Research·Tahereh KalantariAbdolmohamad Rostami
Aug 14, 2012·Journal of Cellular and Molecular Medicine·Katerina VopenkovaJaroslav Michalek
Nov 20, 2012·The American Journal of Pathology·Jian YeGuangyong Peng

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Human Vaccines & Immunotherapeutics
Erika J SchnebleGeorge E Peoples
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
Matthias SchottJochen Seissler
International Journal of Urology : Official Journal of the Japanese Urological Association
Takeshi AzumaTadaichi Kitamura
© 2021 Meta ULC. All rights reserved